New recommendations for the diagnosis of Pulmonary Embolism

December 03, 2006

Diagnosis of Pulmonary Embolism (PE) is a challenging process. Because PE is only present in about one-third of those in whom it is suspected, the diagnosis must be confirmed or excluded by further testing. In an article in the December issue of The American Journal of Medicine, researchers describe the diagnostic pathways that can be used to achieve an accurate and safe diagnosis of PE.

Based on the results from the Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED II) and other studies, these guidelines include both evidence-based recommendations and opinions based on information available at this time.

Writing in the article, Paul D. Stein, MD, states "[we] recommend stratification of all patients with suspected pulmonary embolism according to an objective probability assessment. A negative D-dimer rapid ELISA with a low or moderate probability clinical assessment can safely exclude pulmonary embolism. If pulmonary embolism is not excluded, CT angiography/CT venography is recommended by most PIOPED II investigators, although CT angiography alone is an option. In patients with discordant findings on clinical assessment and CT imaging, further evaluation depends on clinical judgment. In pregnant women and women of reproductive age, ventilation/perfusion scans are recommended by many PIOPED II investigators as the first imaging test."

In an accompanying commentary, James E. Dalen, MD, MPH, describes how various techniques for the diagnosis of PE have been introduced over the last 40 years, each with advantages and disadvantages in accuracy, risk to the patient and cost. Writing about the article, he states, "These recommendations from the PIOPED investigators will have a major impact on the diagnosis and treatment of pulmonary embolism."
-end-
The study is "Diagnostic Pathways in Acute Pulmonary Embolism: Recommendations of The PIOPED II Investigators" by Paul D. Stein, MD, Pamela K. Woodard, MD, John G. Weg, MD, Thomas W. Wakefield, MD, Victor F. Tapson, MD, H. Dirk Sostman, MD, Thomas A. Sos, MD, Deborah A. Quinn, MD, Kenneth V. Leeper, Jr, MD, Russell D. Hull, MBBS, MSc, Charles A. Hales, MD, Alexander Gottschalk, MD, Lawrence R. Goodman, MD, Sarah E. Fowler, PhD, and John D. Buckley, MD, MPH. The commentary is "Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED I, II, and III) and the Diagnosis of Pulmonary Embolism" by James E. Dalen, MD, MPH. These appear in The American Journal of Medicine, Volume 119, Issue 12 (December 2006), published by Elsevier.

Elsevier Health Sciences

Related Pulmonary Embolism Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

High risk of deep vein thrombosis and pulmonary embolism in patients with COVID-19
In a systematic review of the worldwide published data on ''Venous thromboembolism (VTE) in COVID-19 patients'', researchers from the Department of Medicine I (MedUni Vienna), provide an in-depth analysis on the risk of VTE in patients hospitalised for COVID-19.

Trial clarifies which patients with acute pulmonary embolism can be managed at home
Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today at ESC Congress 2020.1 Principal investigator Professor Pierre-Marie Roy of the University Hospital of Angers, France said: ''The pragmatic Hestia method was at least as safe as the sPESI score for triaging haemodynamically stable pulmonary embolism patients for outpatient care.''

Barriers exist to using risk stratification tools to evaluate pulmonary embolism in the ED
Common barriers exist to the use of risk stratification tools in the evaluation of pulmonary embolism in the emergency department and provide insight into where to focus efforts for future implementation endeavors.

Pulmonary embolism and COVID-19
Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients.

Is pulmonary rehab after hospitalization for COPD associated with better survival?
Claims data for nearly 200,000 Medicare patients were used to examine the association between starting pulmonary rehabilitation within 90 days of being hospitalized for chronic obstructive pulmonary disease (COPD) and survival after one year.

Short or long sleep associated with Pulmonary Fibrosis
Scientists have discovered that people who regularly sleep for more than 11 hours or less than 4 hours are 2-3 times more likely to have the incurable disease, pulmonary fibrosis, compared to those that sleep for 7 hours in a day.

Better way to interpret blood tests to diagnose pulmonary embolism
A study led by Hamilton researchers has found a new way to interpret blood test results in patients who are investigated for blood clots in their lungs, a condition known as pulmonary embolism.

Reversed halo signs manifest in septic pulmonary embolism due to IV drug use
According to an article published ahead-of-print in the January 2020 issue of the American Journal of Roentgenology (AJR), reversed halo signs were frequently observed on the chest CT scans of patients with IV substance use disorder-related septic pulmonary embolism.

Treating pulmonary embolism: How safe and effective are new devices?
A new scientific statement from the American Heart Association identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism.

Read More: Pulmonary Embolism News and Pulmonary Embolism Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.